| SCHEDULE OF NET INCOME (LOSS) PER COMMON SHARE |
The
net income (loss) per common share amounts were determined as follows:
SCHEDULE OF NET INCOME (LOSS) PER COMMON SHARE
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| | |
For the Three
Months Ended | | |
For the Six
Months Ended | |
| | |
August
31, | | |
August
31, | |
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| Numerator: | |
| | | |
| | | |
| | | |
| | |
| Net income (loss) | |
$ | (6,838,473 | ) | |
$ | 763,064 | | |
$ | (12,554,310 | ) | |
$ | (3,830,953 | ) |
| Deduct : Dividend on Series
C shares | |
| (315,405 | ) | |
| (29,871 | ) | |
| (408,877 | ) | |
| (29,871 | ) |
| Net income (loss )available to common shareholders | |
| (7,153,878 | ) | |
| 733,193 | | |
| (12,963,187 | ) | |
| (3,860,824 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Denominator: | |
| | | |
| | | |
| | | |
| | |
| Weighted average shares – basic | |
| 451,014,825 | | |
| 184,694,421 | | |
| 388,485,442 | | |
| 169,935,566 | |
| | |
| | | |
| | | |
| | | |
| | |
| Net income (loss) per
share – basic | |
$ | (0.02 | ) | |
$ | 0.00 | | |
$ | (0.03 | ) | |
$ | (0.02 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Dilutive effect of common stock equivalents: | |
| | | |
| | | |
| | | |
| | |
| Convertible Series C Preferred Shares | |
| — | | |
| 7,045,296 | | |
| — | | |
| — | |
| Convertible Series F Preferred Shares | |
| — | | |
| 682,680,273 | | |
| — | | |
| — | |
| Stock options and warrants | |
| — | | |
| 2,261,775 | | |
| — | | |
| — | |
| | |
| — | | |
| 691,987,344 | | |
| — | | |
| — | |
| Denominator: | |
| | | |
| | | |
| | | |
| | |
| Weighted average shares – diluted | |
| 451,014,825 | | |
| 876,681,766 | | |
| 388,485,442 | | |
| 169,935,566 | |
| | |
| | | |
| | | |
| | | |
| | |
| Net income (loss) per
share – diluted | |
$ | (0.02 | ) | |
$ | 0.00 | | |
$ | (0.03 | ) | |
$ | (0.02 | ) |
|
| SCHEDULE OF ANTI-DILUTIVE SHARES OF COMMON STOCK EQUIVALENTS |
The
anti-dilutive shares of common stock equivalents for the three and six months ended August 31, 2026 and 2025 were as follows:
SCHEDULE OF ANTI-DILUTIVE SHARES OF COMMON STOCK EQUIVALENTS
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| | |
For the Three
Months Ended | | |
For the Six
Months Ended | |
| | |
August
31, | | |
August
31, | |
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| | |
| | |
| | |
| | |
| |
| Convertible or exchangeable debt
and accrued interest | |
| 14,478,810,811 | | |
| — | | |
| 14,478,810,811 | | |
| — | |
| Convertible Series C Preferred Shares | |
| 96,587,891 | | |
| — | | |
| 96,587,891 | | |
| 7,045,296 | |
| Convertible Series F Preferred Shares | |
| 2,057,094,397 | | |
| — | | |
| 2,057,094,397 | | |
| 682,680,273 | |
| Stock options and warrants | |
| 2,202,121 | | |
| — | | |
| 2,202,121 | | |
| 2,261,775 | |
| Total | |
| 16,634,695,220 | | |
| — | | |
| 16,634,695,220 | | |
| 691,987,344 | |
|